Markets:

Overview

News

Currencies

International

Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

83.05 -0.73 (-0.87%)

Streaming Delayed Price Updated: 2:13 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021 ↗

September 16, 2021

Upgrades For Signet Jewelers Ltd (NYSE:

Via Benzinga

Is This Under-the-Radar Medical Device Company a Post-Earnings Buy? ↗

August 06, 2021

LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.

Via The Motley Fool

Lemaitre Vascular Inc (LMAT) Q2 2021 Earnings Call Transcript ↗

July 30, 2021

LMAT earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

34 Stocks Moving In Wednesday's Mid-Day Session ↗

July 14, 2021

Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution...

Via Benzinga

Earnings Scheduled For April 29, 2021 ↗

April 29, 2021

Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...

Via Benzinga

55 Biggest Movers From Yesterday ↗

July 15, 2021

Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by...

Via Benzinga

LeMaitre Vascular Sees Better Than Expected Q2 Sales, Raises $55M Via Equity At 9% Discount ↗

July 14, 2021

LeMaitre Vascular Inc (NASDAQ: LMAT) has announced preliminary Q2 2021 results and sees net sales of $40.7 million compared to an estimated $37.9 million, up 64%Y/...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 13, 2021

Gainers scPharmaceuticals (NASDAQ:SCPH) ...

Via Benzinga

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike? ↗

July 12, 2021

Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?

Via The Motley Fool

Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level ↗

July 01, 2021

Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist?

Via Investor's Business Daily

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

June 21, 2021

Monday's morning session saw 49 companies set new 52-week highs. Intriguing Points: The largest company by market cap to hit a new 52-week high was Shopify (...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

Edwards Lifesciences Stock Gets Revived With Relative Strength Rating Upgrade ↗

June 15, 2021

The Relative Strength (RS) Rating for Edwards Lifesciences stock headed into a higher percentile Tuesday, as it got a lift from 67 to 71.

Via Investor's Business Daily

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Analyzing LeMaitre Vascular's Ex-Dividend Date ↗

May 17, 2021

LeMaitre Vascular (NASDAQ:LMAT) declared a dividend payable on June 3, 2021 to its shareholders as of April 27, 2021. It was also announced that shareholders of LeMaitre Vascular'...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of...

Via Benzinga

LeMaitre Vascular inc (LMAT) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

LMAT earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: LeMaitre Vascular Q1 Earnings ↗

April 29, 2021

Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.